Measured VT and BPND Values of 18F-Nifene
| 1TCM | Logan with blood sampling | ||||||
| Subject no. | Region | VT (mL/cm3) | BPND* | VT (mL/cm3) | BPND | MRTM, BPND | Logan ref, BPND |
| M1 | CB | 7.44 | 7.68 | ||||
| AVT | 20.41 | 1.74 | 20.83 | 1.71 | 1.70 | 1.68 | |
| LG | 18.56 | 1.50 | 19.11 | 1.49 | 1.45 | 1.44 | |
| FC | 9.04 | 0.22 | 9.31 | 0.21 | 0.20 | 0.20 | |
| SB | 9.26 | 0.25 | 9.50 | 0.24 | 0.24 | 0.24 | |
| M2 | CB | 6.28 | 6.13 | ||||
| AVT | 16.98 | 1.70 | 16.43 | 1.68 | 1.67 | 1.67 | |
| LG | 15.29 | 1.44 | 15.11 | 1.46 | 1.45 | 1.44 | |
| FC | 8.06 | 0.28 | 7.92 | 0.29 | 0.28 | 0.28 | |
| SB | 8.25 | 0.31 | 8.03 | 0.31 | 0.30 | 0.30 | |
| M3 | CB | 6.48 | 6.18 | ||||
| AVT | 16.93 | 1.61 | 15.54 | 1.51 | 1.54 | 1.52 | |
| LG | 14.97 | 1.31 | 13.97 | 1.26 | 1.26 | 1.27 | |
| FC | 8.89 | 0.37 | 8.27 | 0.34 | 0.34 | 0.34 | |
| SB | 9.10 | 0.40 | 8.56 | 0.39 | 0.38 | 0.38 | |
| M4 | CB | 7.42 | 7.49 | ||||
| AVT | 17.47 | 1.35 | 17.86 | 1.38 | 1.44 | 1.35 | |
| LG | 15.85 | 1.14 | 16.29 | 1.17 | 1.20 | 1.14 | |
| FC | 8.78 | 0.18 | 9.11 | 0.22 | 0.21 | 0.20 | |
| SB | 9.25 | 0.25 | 9.33 | 0.25 | 0.25 | 0.24 | |
| Average ± SD | CB | 6.91 ± 0.61 | 6.87 ± 0.83 | ||||
| AVT | 17.95 ± 1.66 | 1.60 ± 0.17 | 17.67 ± 2.32 | 1.57 ± 0.15 | 1.59 ± 0.12 | 1.56 ± 0.15 | |
| LG | 16.17 ± 1.64 | 1.35 ± 0.16 | 16.12 ± 2.21 | 1.35 ± 0.15 | 1.34 ± 0.13 | 1.32 ± 0.15 | |
| FC | 8.69 ± 0.43 | 0.26 ± 0.08 | 8.65 ± 0.66 | 0.26 ± 0.06 | 0.26 ± 0.07 | 0.26 ± 0.07 | |
| SB | 8.96 ± 0.48 | 0.30 ± 0.07 | 8.86 ± 0.69 | 0.29 ± 0.07 | 0.29 ± 0.06 | 0.29 ± 0.07 | |
↵* BPND for 1TCM was calculated as VT/VT(CB) − 1.
CB = cerebellum; AVT = anteroventral thalamus; LG = lateral geniculate body; FC = frontal cortex; SB = subiculum.